CA
NZ
UK
AU
IND
US
…
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products, as well as an online dispensary. In addition, the company provides veterinary instrumentation supply and property development services. The company was founded in 1999 and is headquartered in Diss, the United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Income before tax | 32.60M | 38.20M | 53.90M | 36.00M | 33.10M |
| Minority interest | - | -0.20M | - | - | - |
| Net income | 19.30M | 6.20M | 41.90M | 25.70M | 19.30M |
| Selling general administrative | - | 227.10M | 200.00M | 196.30M | 181.80M |
| Gross profit | 259.70M | 277.90M | 262.30M | 239.10M | 221.90M |
| Reconciled depreciation | - | 58.50M | 50.40M | 47.60M | 48.10M |
| Ebit | 49.80M | 49.90M | 61.30M | 42.50M | 40.10M |
| Ebitda | 114.30M | 108.40M | 111.70M | 90.10M | 88.20M |
| Depreciation and amortization | 64.50M | 58.50M | 50.40M | 47.60M | 48.10M |
| Operating income | 71.80M | 50.80M | 62.30M | 42.80M | 40.10M |
| Other operating expenses | 601.40M | 596.50M | 546.00M | 511.40M | 470.00M |
| Interest expense | 17.20M | 12.60M | 7.40M | 6.80M | 7.00M |
| Tax provision | - | 11.80M | 12.00M | 10.30M | 13.80M |
| Interest income | - | - | - | - | 7.00M |
| Net interest income | - | -12.60M | -8.40M | -6.80M | -7.00M |
| Income tax expense | 13.50M | 11.80M | 12.00M | 10.30M | 13.80M |
| Total revenue | 673.20M | 647.30M | 608.30M | 554.20M | 510.10M |
| Total operating expenses | 187.90M | 227.10M | 200.00M | 196.30M | 181.80M |
| Cost of revenue | 413.50M | 369.40M | 346.00M | 315.10M | 288.20M |
| Total other income expense net | -39.20M | -12.60M | -8.40M | -6.80M | -7.00M |
| Net income from continuing ops | - | 26.40M | 41.90M | 25.70M | 19.30M |
| Net income applicable to common shares | - | - | 41.90M | 25.70M | 19.30M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Total assets | 696.20M | 690.00M | 572.30M | 518.20M | 484.50M |
| Intangible assets | 105.90M | 113.20M | 93.60M | 95.90M | 114.50M |
| Other current assets | 13.40M | 24.80M | 52.70M | 52.70M | 48.20M |
| Total liab | 394.50M | 429.50M | 315.30M | 300.80M | 293.40M |
| Total stockholder equity | 299.80M | 260.40M | 257.00M | 217.40M | 191.10M |
| Other current liab | 57.20M | 17.90M | -78.40M | -78.40M | 32.70M |
| Common stock | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M |
| Capital stock | - | 0.10M | 0.10M | 0.10M | 0.10M |
| Retained earnings | 198.30M | 211.20M | 209.10M | 171.10M | 149.10M |
| Other liab | - | - | 24.80M | 20.00M | 20.80M |
| Good will | 231.70M | 221.70M | 162.50M | 120.60M | 113.90M |
| Other assets | - | - | - | 2.30M | - |
| Cash | 16.10M | 16.50M | 21.50M | 49.00M | 33.70M |
| Total current liabilities | 123.30M | 118.10M | 105.10M | 101.40M | 98.50M |
| Current deferred revenue | 1.60M | 2.30M | 128.70M | 83.80M | -28.80M |
| Net debt | 232.70M | 271.30M | 177.60M | 139.80M | 149.00M |
| Short term debt | 15.20M | 27.80M | 13.30M | 9.40M | 8.60M |
| Short long term debt | - | - | - | - | 0.00M |
| Short long term debt total | 248.80M | 287.80M | 199.10M | 188.80M | 182.70M |
| Other stockholder equity | 109.10M | 47.60M | 47.80M | 46.20M | 41.90M |
| Property plant equipment | - | - | 204.40M | 171.40M | 154.60M |
| Total current assets | 135.40M | 128.60M | 111.80M | 127.90M | 101.40M |
| Net tangible assets | - | - | 0.50M | 0.90M | -37.30M |
| Short term investments | - | - | - | - | 1.20M |
| Net receivables | 77.40M | 55.50M | 28.90M | 52.70M | 39.60M |
| Long term debt | - | 181.30M | 92.20M | -84.30M | 83.90M |
| Inventory | 28.50M | 31.80M | 28.40M | 26.20M | 19.50M |
| Accounts payable | 49.30M | 50.10M | 41.50M | 86.60M | 86.00M |
| Accumulated other comprehensive income | -7.70M | 1.50M | - | - | - |
| Common stock total equity | - | - | - | - | 0.10M |
| Non currrent assets other | - | 0.90M | 2.40M | 2.40M | 0.10M |
| Non current assets total | 560.80M | 561.40M | 460.50M | 390.30M | 383.10M |
| Capital lease obligations | - | 106.50M | 106.90M | -104.50M | 98.80M |
| Breakdown | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
| Investments | - | -140.50M | -99.90M | -12.40M | -35.40M |
| Change to liabilities | - | - | -0.80M | -0.10M | -5.20M |
| Total cashflows from investing activities | -22.70M | -140.50M | -99.90M | -45.10M | -35.40M |
| Net borrowings | - | 88.70M | -4.40M | -12.80M | -14.10M |
| Total cash from financing activities | -59.20M | 68.30M | -12.10M | -15.10M | -12.60M |
| Change to operating activities | - | - | -1.40M | -1.80M | -1.10M |
| Net income | 18.90M | 6.40M | 41.90M | 25.70M | 19.30M |
| Change in cash | -0.40M | -5.00M | -27.50M | 15.30M | 12.20M |
| Begin period cash flow | 16.50M | 21.50M | 49.00M | 33.70M | 21.50M |
| End period cash flow | 16.10M | 16.50M | 21.50M | 49.00M | 33.70M |
| Total cash from operating activities | 82.10M | 67.80M | 84.50M | 75.50M | 60.20M |
| Issuance of capital stock | - | 2.40M | 2.10M | 2.30M | 1.50M |
| Depreciation | 64.50M | 58.50M | 50.40M | 47.60M | 48.10M |
| Other cashflows from investing activities | 42.30M | -3.60M | - | - | -18.80M |
| Dividends paid | 5.70M | 5.40M | 5.00M | 4.60M | 3.90M |
| Change to inventory | 2.90M | -3.00M | -1.80M | -6.60M | -0.40M |
| Change to account receivables | -9.90M | -17.40M | -4.60M | -3.20M | -3.40M |
| Sale purchase of stock | - | -0.90M | -1.20M | 4.60M | 3.90M |
| Other cashflows from financing activities | -16.60M | -16.50M | -7.20M | -12.70M | -13.00M |
| Change to netincome | - | - | -0.20M | 13.90M | 2.90M |
| Capital expenditures | 26.40M | 43.10M | 45.70M | 24.50M | 16.60M |
| Change in working capital | -2.70M | -10.50M | -8.60M | -11.70M | -10.10M |
| Stock based compensation | - | 2.40M | 1.70M | 2.30M | 2.20M |
| Other non cash items | 3.90M | 11.80M | 10.70M | 6.80M | 7.00M |
| Free cash flow | 55.70M | 24.70M | 38.80M | 51.00M | 43.60M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CVSG CVS Group Plc |
12.00 0.92% |
1316.00 | 50.87 | 12.08 | 1.18 | 2.69 | 1.52 | 9.51 |
| SPI Spire Healthcare Group Plc |
- -% |
248.50 | 37.06 | 13.91 | 0.38 | 0.78 | 1.18 | 7.70 |
| OHGR One Health Group Plc |
2.00 0.65% |
310.00 | 24.09 | 18.15 | 1.06 | 2.75 | 0.75 | 10.53 |
| KNB Kanabo Group PLC |
-0.22 99.02% |
0.00 | - | - | 1.25 | 0.24 | 0.07 | -2.21 |
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products, as well as an online dispensary. In addition, the company provides veterinary instrumentation supply and property development services. The company was founded in 1999 and is headquartered in Diss, the United Kingdom.
| Name | Title | Year Born |
|---|---|---|
| Mr. Richard William Mark Fairman F.C.A. | CEO & Director | 1967 |
| Mr. Robin Jay Alfonso F.C.A. | CFO & Director | 1979 |
| Mr. Benjamin David Jacklin M.A., MA, VetMB, MVetMed, DipECVS, MRCVS | COO & Director | 1984 |
| Mr. Gordon Palmer | Head of IT | NA |
| Mr. Enrico Tizzano | Chief Technology Officer | NA |
| Ms. Helen Finney | Group HR Director | NA |
| Mr. Paul Higgs | Chief Veterinary Officer | NA |
| Ms. Jenny Farrer | Group Company Sec. | 1977 |
| Mr. Zak Leavold | Commercial Director | NA |
| Mr. Robert Dawson | Small Animal Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...